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tumor-derived primary cells are essential for in vitro and in vivo studies of tumor biology. the scarcity 
of this cellular material limits the feasibility of experiments or analyses and hence hinders basic and 
clinical research progress. We set out to determine the minimum number of cells that can be analyzed 
with standard laboratory equipment and that leads to reliable results, unbiased by cell number. A 
proof-of-principle study was conducted with primary human monocyte-derived macrophages, seeded 
in decreasing number and constant cell density. Gene expression of cells stimulated to acquire opposite 
inflammatory states was analyzed by quantitative PCR. Statistical analysis indicated the lack of 
significant difference in the expression profile of cells cultured at the highest (100,000 cells) and lowest 
numbers (3,610 cells) tested. Gene Ontology, pathway enrichment and network analysis confirmed the 
reliability of the data obtained with the lowest cell number. this statistical and computational analysis 
of gene expression profiles indicates that low cell number analysis is as dependable and informative as 
the analysis of a larger cell number. Our work demonstrates that it is possible to employ samples with a 
scarce number of cells in experimental studies and encourages the application of this approach on other 
cell types.
The use of primary cells in basic and clinical research is of upmost importance and interest because it facilitates 
the analysis of a biological material whose physiological properties (e.g. morphology, phenotype, function) are 
much less compromised than those of established, immortalized cell lines1. However, experimenting with these 
cells entails some restrictions due to (i) their properties (e.g. the (epi)genetic uniqueness of each donor), (ii) 
technical (e.g. differences resulting from the preparation of each sample) and (iii) practical issues (e.g. limited 
amount of material). This is a recurrent question in cancer research where researchers must deal not only with 
the high heterogeneity of the biological tissues of interest but also with problems associated with their physical 
availability and accessibility. This is the case, for instance, with the cellular material that can be obtained from 
biopsies of glioblastoma. Those brain tumors are characterized by a high level of molecular and cellular heteroge-
neity, which largely contribute to their resistance to therapy2,3. Tumor-associated microglia/macrophages (TAMs) 
constitute one subpopulation of glioblastoma cells that efficiently support tumor growth4,5 and, as such, represent 
attractive therapeutic targets6. Targeting these cells for therapeutic purposes necessitates a thorough knowledge 
of their properties. This knowledge has tremendously increased in the last few years thanks to experimental work 
performed with human primary microglia/macrophages7–14. However, the study of these highly plastic cells still 
poses experimental challenges. For instance, the patient to patient variability in terms of amount and quality of 
cells isolated from glioblastoma resections limits the extent and range of assays. Furthermore, discrete cellular 
phenotypic or functional profiles might vary with the location of the cells in the tumor or with their origin (resi-
dent microglia versus infiltrating macrophages). This heterogeneity and its biological significance typically cancel 
out in the analysis of cells pooled from the whole tumor. Two approaches might be considered to circumvent 
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these limitations: the use of single-cell analysis or the use of a very low number of cells. Both would have to com-
ply with the requirement of full reliability in the data generated by each setup.
Single cell profiling, namely single cell-RNA sequencing, combined with bioinformatics, is becoming a main-
stream methodology to characterize the transcriptome of individual cells. A recent publication has reported 
profiles of TAMs freshly isolated from brain tumor biopsies, indicating the feasibility of this approach for such 
heterogeneous tumors15. The measurement of gene expression in single cells however has a number of experimen-
tal pitfalls such as the so-called “dropout event” or lack of detection of some RNAs16,17. More worryingly, highly 
plastic cells such as microglia or macrophages are expected to exhibit temporal fluctuation in gene expression. 
This transcriptional burst is covered in the transcriptome analysis of cell populations but not in a single cell analy-
sis. As a consequence, different intermediate transcriptional states of TAMs - that would be part of a longitudinal 
and regional TAM signature - will be lost in a single cell analysis and hidden in the analysis of a large number 
of cells but will be kept in the analysis of a small number of cells. These intermediate states potentially represent 
relevant therapeutic targets, making the analysis of a limited number of reactive cells -such as cells of the immune 
system- more relevant than that of individual cells. The limitations and reliability of this approach have not been 
systematically determined yet. Reducing cell numbers might increase the variability in gene expression according 
to the law of large numbers. The response of highly plastic cells to the same external stimuli might as well differ 
according to their number. Thus, what is the minimum number of cells that we can analyze and that will lead to 
results that are not significantly different from those obtained with a more standard number of cells?
To answer this question, we investigated how much we can reduce the number of cells without affecting the 
gene expression profile analyzed by standard procedures that they would exhibit when analyzed at a higher cell 
number. As a cellular model, we used human primary monocyte-derived macrophages (MDMs). Besides rep-
resenting the precursors of macrophages that infiltrate tumors, these cells offer the advantages of being easily 
isolated from various donors (biological variation) and having a well-characterized response to inflammatory 
stimuli18,19. In order to simulate in vivo conditions in which macrophages are exposed to multiple pro- and/or 
anti-inflammatory stimuli, we treated MDMs with two Toll-like receptor (TLR) ligands or with two cytokines to 
polarize them towards a defined pro- or anti-inflammatory status, respectively. Cells were seeded in decreasing 
amount but at the same density in multi-well plates with various diameters. Following treatment, the resulting 
macrophage states were characterized by RT-qPCR. Gene expression levels in cells seeded at the highest cell 
number were compared with levels in cells seeded at the lower cell numbers. Statistical analyses were carried out 
to assess the degree of change between the two conditions and to select the lowest possible number of cells that 
maintains sensitivity of and reliability in the gene expression measurements. Finally, we performed functional 
enrichment and network analyses with these data as a means to understand the biological processes and molecu-
lar interactions that are perturbed under changing conditions.
Results
Decreasing the number of cells does not affect the expression level of a selected set of 
genes. In order to determine the lowest number of cells that enables a reliable detection of gene expression, 
comparable to that detected in high cell numbers, we first analyzed mRNA levels of a small set of genes in MDMs 
after 24 h of treatment with lipopolysaccharide (LPS) and polyinosinic-polycytidylic acid (poly(I:C)) (hereinaf-
ter referred to as M(LPS/IC)). LPS, a ligand of TLR-4, and poly(I:C), a ligand of TLR-3, are pro-inflammatory 
molecules that trigger tumoricidal activities of macrophages and TAMs8,18. Cells from the same macrophage 
preparation were seeded at various numbers but at constant density in vessels of decreasing size (see Table 1). 
The highest number of cells we tested, referred to as standard number of cells, was 100,000 cells seeded in one 
well of a 6-well plate. The lowest vessel we tested was the well of a 96-well plate in which 3,610 cells were seeded. 
We did not assay a lower number of cells because it would be impractical for any type of molecular analysis using 
standard methodologies and equipment.
We first assessed whether the applied stimulus affects cell viability. As shown in Fig. 1, there were no significant 
changes in cell viability after 24 h of stimulation at any seeded cell number. We next analyzed and compared the expres-
sion of a set of 6 genes in cells seeded at the standard number (6-well plate) and at the lowest number (96-well plate). 
RNA extraction and RT-qPCR were performed with technical replicates consisting of individual wells of the 6-well 
plates and a pool of two wells of the 96-well plates. After 24 h of pro-inflammatory treatment with the LPS/poly(I:C) 
combination, cells seeded at the highest number (100,000 cells per well in 6-well plates) exhibited the expected profile. 
Gene expression of IL1B and SLC1A2 was upregulated18,20, that of CD163 and CD206 was downregulated18,21, whereas 
that of GAPDH (our unpublished observations) and GLUL22 were not altered (Fig. 2A). An expression profile similar 
to that of the standard condition was observed for cells seeded at the lowest number (Fig. 2B). The statistical analysis of 
Multiple well 
plate
Area/well 
(cm2)
Seeded cell 
number/well
µl medium/
well
6 well 8,87 100,000 4,000
12 well 3,90 44,000 1,760
24 well 1,90 21,400 860
48 well 1,00 11,300 450
96 well 0,32 3,610 140
Table 1. Seeding conditions of monocyte-derived macrophages in vessels of different size. To keep the cell 
density identical, the cell number per vessel was calculated by dividing the vessel area by the reference vessel 
area (8,87 cm2) and multiplying the result by the standard cell number (100,000).
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these data (see the Materials and Methods) did not show significant differences between the standard condition and the 
lowest cell number (Fig. 2C). From these results we concluded that it is possible to decrease the number of cultured cells 
to a minimum of 3,610 cells per well of a 96-well plate without inducing significant changes in the expression of a panel 
of genes. In the next experiments, gene expression levels were analyzed and compared in cells seeded in the standard 
condition (6-well plates) and cells seeded at the lowest number (96-well plates).
Different stimuli induce the expected gene expression profile independently of cell number. 
We next analyzed gene expression in MDMs treated with an anti-inflammatory stimulus and compared it 
with the MDM response to the pro-inflammatory stimulus. These stimuli are expected to induce distinct 
Figure 1. Viability of human MDMs 24 h after treatment with LPS and poly(I:C). Data are expressed as viability 
of treated cells relative to viability of untreated cells. Values are means ± SD of at least three technical replicates. 
Statistical analysis was performed using a two-tailed t-test. Calculated p-values: 6 well, untreated vs M1: 0.1683; 
12 well, untreated vs M1: 0.6438; 24 well, untreated vs M1: 0.8825; 48 well, untreated vs M1: 0.1370; 96 well, 
untreated vs M1: 0.1180.
Figure 2. Relative gene expression of human MDMs seeded in 6-well or 96-well plates, 24 h after M(LPS/IC) 
stimulation (M1) or absence of stimulation (Mock). (A) qPCR analysis of 6-well samples. (B) qPCR analysis 
of 96-well samples. M1 values are relative to mock which is normalized to 1. Average RQs of three technical 
replicates ± SD are shown. Technical replicates: individual wells of a 6-well plate, pool of two wells of a 96-well 
plate. Reference genes: SDHA, HPRT1. (C) Scatter plot showing the statistical comparison between seeding 
conditions for matched treatments. Dashed lines correspond to the significance level ɑ = 0.05.
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pro-inflammatory and anti-inflammatory phenotypes that should translate into the opposite expression pro-
file of the inflammatory genes IL1B, CD163 and CD20618,21. Cells from individual preparations of MDMs were 
seeded in 6- and 96-well plates and were left untreated or were incubated for 24 h with the pro-inflammatory 
M(LPS/IC) stimulus or with the anti-inflammatory combination of the interleukin-4 (IL-4) and interleukin-10 
(IL-10) (M(IL-4/IL-10)) stimuli. After having excluded possible cytotoxic effects of the M(IL-4/IL-10) stimuli 
(Fig. 3), gene expression was analyzed by RT-qPCR. Consistent with our observations (see Fig. 2), M(LPS/IC) 
stimulation induced the expected pro-inflammatory profile. That is, upregulation of the pro-inflammatory IL1B 
and downregulation of the anti-inflammatory CD163 and CD206, both in MDMs seeded at the standard and at 
the lowest number of cells (Fig. 4). M(IL-4/IL-10) stimulation did not alter the level of IL1B or CD163 expressed 
by untreated macrophages, suggesting a basal anti-inflammatory status of these cultured MDMs for which the 
expression of these genes could not be modulated further by the IL-4/IL-10 stimulus. It did, however, increase 
the level of CD206 expression, indicating that MDMs were responsive to the anti-inflammatory stimulus. This 
expression profile was observed both for cells seeded at the standard and lower numbers (Fig. 4A,B). The statis-
tical analysis of these data did not show significant differences between the standard condition and the lower cell 
numbers (Fig. 4C,D). These results confirm that it is possible to decrease the number of cultured cells to a mini-
mum of 3,610 cells without inducing significant changes in gene expression, independently of the type of stimulus 
to which the cells were subjected.
Analysis of a larger set of genes confirms the similarity of the gene expression profiles in stand-
ard and low numbers of MDMs. To further demonstrate that the gene expression profile detected in the 
low number of cells is similar to the profile detected in a larger number of the same cells, we extended our analysis 
to a broader spectrum of 28 genes. We included genes whose expression is regulated during inflammation and 
that code for: proteins involved in the immune response (e.g. TGFß, TNF), (metabolic) enzymes (e.g. arginase, 
dipeptidyl peptidase 4) and metabolite transporters (e.g. EAAT2, xCT). Selection of these genes was based on 
reported data, as well as on our own unpublished observations (see Table 2 for the complete list of genes). MDMs 
were seeded in 6-well plates and in 96-well plates and were either left untreated or were treated with the M(LPS/
IC) or the M(IL-4/IL-10) stimulus for 24 h. Extracted RNA was then analyzed by quantitative RT-qPCR. Analysis 
of 28 genes with RT-qPCR requires more RNA than the amount that it is possible to extract from 3,610 cells. This 
analysis was therefore conducted with technical replicates consisting of a pool of thirty-two wells of the 96-well 
plates. The robustness of the qPCR was increased by including three instead of two reference genes (SDHA, 18 S 
and GAPDH; see Materials and Methods). With the exception of five genes (ARG1, IFNG, IL4, IL6, IL13), all 
the genes listed in Table 2 were detectable in all tested conditions. The same profile was observed in both setups 
(Fig. 5A,B). The statistical analysis of these data confirmed that there were no significant differences between the 
two setups (Fig. 5C). These results indicate that we can perform an unbiased evaluation of the expression of a few 
genes of interest in a low number of cells.
Gene ontology and pathway enrichment analysis of dysregulated genes. We finally examined the 
validity of our approach through a bioinformatics analysis in order to determine and compare pathways altered in 
treated MDMs seeded at the standard and low numbers. The rationale was that both seeding conditions should result 
in similar sets of differentially expressed genes and that these genes should be involved in biological processes related to 
the induced pro- or anti-inflammatory responses. For that purpose, we further analyzed the data generated by the PCR 
array and determined the genes whose expression showed significant changes after treatment with the M(LPS/IC) and 
the M(IL-4/IL-10) stimuli. Volcano plots were generated for each differential gene expression analysis (see Materials 
and Methods): untreated versus M(LPS/IC), untreated versus M(IL-4/IL10) and M(LPS/IC) versus M(IL-4/IL-10), in 
both setups (Fig. 6). Only genes whose change in expression was at least 1.5-fold larger than the standard condition are 
indicated by name in Fig. 6. Among those genes, CD206, IL1B, SHPK, VEGFA and GGH displayed the most robust 
profile of expression, being identified in each condition and setup. Also note that regardless of the seeding condition 
(6-well or 96-well plates), the differential gene expression analysis led to similar gene lists.
Figure 3. Cell viability of human MDMs 24 h after stimulation with LPS and poly(I:C) (black) or IL-4 and IL-10 
(grey). All values are means ± SD of at least three independent experiments. Statistical analysis was performed 
using the Kruskal-Wallis method. Comparison of M(LPS/IC) vs M(IL-4/IL-10) vs untreated cells revealed no 
significant differences.
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We then searched for the biological processes and pathways associated with genes differentially expressed 
in the M(LPS/IC) and M(IL-4/IL-10) macrophages. GO and pathway enrichment analysis using the Reactome 
database are shown for the 6-well and 96-well plate setups (Fig. 7). Both seeding conditions led to very similar 
GO terms and Reactome pathways. Indeed, more than 50% of the GO terms and pathways were shared by both 
conditions whereas other GO terms and pathways presented high similarity. For instance, the upregulated GO 
terms “positive regulation of neuroinflammatory response” and “lipopolysaccharide-mediated signaling path-
way” were found exclusively in the standard condition and the low cell condition, respectively. These two terms 
obviously refer to the same biological process that is inflammation, which we expect to be induced in M(LPS/IC) 
macrophages. Similarly, the GO terms “phagocytic cup” and “membrane raft” were found exclusively in the stand-
ard condition and the low number of cells condition respectively and refer both to membrane dynamics. These 
differences are most likely to be explained by the still “low” number of genes we analyzed and would disappear by 
increasing the number of tested genes. We thus can conclude that, when we use a low number of cells and identify 
genes of interest, we can trust that the enriched pathways are of value.
The results of the GO and pathway enrichment analysis prompted us to perform a network analysis with 
genes from the low cell number setup. This included all genes showing at least a 1.5-fold up- or downregula-
tion in the M(LPS/IC) vs M(IL-4/IL-10) stimulated macrophages: CD206, SHPK, GLS, GGH, CD163, GLUL, 
SLC7A11, CD14, SLC1A2, TNF, IL1B (see Fig. 6F). Since genes coding for interacting proteins tend to be 
co-regulated, we examined the protein interaction network around the proteins coded by those dysregulated 
genes to point to affected pathways. A reference protein-protein interaction network was constructed using 
high-quality interactions from the HIPPIE database (see Materials and Methods)23. Based on this network, sub-
networks containing only the proteins coded by the up- or down-regulated genes and their one-level neighbors 
(i.e. the proteins that directly interact with them) were built (Fig. 8). This network analysis revealed a connec-
tion between gamma-glutamyl hydrolase (GGH), which is upregulated after M(LPS/IC) stimulation, and other 
pro-inflammatory markers such as TNF. The possible relevance of this metabolic enzyme to the inflammatory 
status and functions of tumor-associated macrophages is discussed below.
Figure 4. Relative gene expression of human MDMs seeded in 6-well or 96-well plates, 24 h after stimulation 
with LPS and poly(I:C) (M1), IL4 and IL-10 (M2) or absence of stimulation (Mock). (A) qPCR analysis of 6-well 
samples. (B) qPCR analysis of 96-well samples. M1 and M2 values are relative to mock which is normalized to 1. 
Average RQs of three technical replicates ± SD are shown. Technical replicates: individual wells of a 6-well plate, 
pool of two wells of a 96-well plate. Reference genes: SDHA, HPRT1. (C,D) Scatter plots showing the statistical 
comparison between seeding conditions for matched treatments (C = M1, D = M2). Dashed lines correspond to 
the significance level ɑ = 0.05.
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Discussion
In this study, we sought to determine the reliability and the limitations in analyzing low numbers of cells in 
terms of their gene expression. Indeed, a decrease in cell number could result in an increased variability in gene 
expression or force changes in their response to external stimuli. We demonstrate that gene expression analysis 
of a low number of cells is as reliable and informative as the analysis of a larger number of cells. We provide an 
experimental workflow to assess the reliability of gene expression measurements of a low cell number using 
RT-qPCR followed by the statistical and computational analysis of the gene expression profiles that we obtained. 
This experimental workflow is applied to human monocyte-derived macrophages and presents a valid framework 
for similar studies with other cell types.
We investigated a cellular experimental system that combines different sources of variability: the genetic back-
ground of healthy blood donors which is reflected in each of the macrophage preparations used for the study; 
the stimuli applied to the cells; and finally, the inherent heterogeneity of an in vitro culture of primary cells. We 
kept the seeding density of the cells constant in order to ensure that we would assess the effect of cell number 
and not that of cell density. Given that our standard number was 100,000 cells/well seeded in a 6-well plate, the 
size of the smallest vessel available for cell culture, the 96-well plate, imposed a constraint of 3,610 cells on the 
lowest number of seeded cells. We did not observe statistical differences in the profile of a given set of genes 
expressed by macrophages from the same preparation and seeded at 3,610 or 100,000 cells. This indicates that, in 
our experimental system, we can lower the number of macrophages to 3,610 without the risk of introducing an 
artefactual variability factor. A practical consequence is that more experiments can be conducted with the same 
batch of cells by using less cells per experiment. In the case of cells isolated from a tissue and that can only be 
extracted in limited amounts, such as tumor-associated macrophages, our results suggest that 3,610 cells would 
be sufficient to obtain statistically reliable gene expression measurements. This low number of cells is indeed not 
meant to be used for the analysis of a large number of parameters (e.g. number of genes) because of the physical 
limit it imposes on the quantity of material to be analyzed (e.g. RNA). As reported in Figs. 2 and 4, assessing the 
expression of seven to eight genes (including two reference genes) with our RT-qPCR protocol required pooling 
Target gene (associated protein) Assay ID
18s Hs99999901_s1
SDHA (Succinate dehydrogenase (ubiquinone) flavoprotein subunit, 
mitochondrial) Hs00188166_m1
HPRT1 (Hypoxanthine-guanine phosphoribosyltransferase) Hs02800695_m1
IL1B (Interleukin-1 beta) Hs01555410_m1
CD163 (Scavenger receptor cysteine-rich type 1 protein M130) Hs00174705_m1
CD206 (Macrophage mannose receptor 1) Hs00267207_m1
GAPDH (Glyceraldehyde-3-phosphate dehydrogenase) Hs02758991_g1
GLUL (Glutamine synthetase) Hs01013056_g1
SLC1A2 (Glutamine synthetase) Hs01102423_m1
SLC7A11 (Cystine/glutamate transporter) Hs00921938_m1
SLC1A5 (Neutral amino acid transporter B(0)) Hs01056542_m1
SLC3A2 (4F2 cell-surface antigen heavy chain) Hs00374243_m1
GLS (Glutaminase kidney isoform, mitochondrial) Hs01014020_m1
GGH (Gamma-glutamyl hydrolase) Hs00914163_m1
OAT (Ornithine aminotransferase, mitochondrial) Hs00236852_m1
CHORDC1 (Cysteine and histidine-rich domain-containing protein 1) Hs00854389_g1
DPP4 (Dipeptidyl peptidase 4) Hs00897386_m1
G6PD (Glucose-6-phosphate 1-dehydrogenase) Hs00166169_m1
ARG1 (Arginase-1) Hs00163660_m1
ARG2 (Arginase-2, mitochondrial) Hs00982833_m1
IL4 (Interleukin-4) Hs00174122_m1
IL6 (Interleukin-6) Hs00174131_m1
IL10 (Interleukin-10) Hs00961622_m1
IL13 (Interleukin-13) Hs00174379_m1
TNF (Tumor necrosis factor) Hs00174128_m1
IFNG (Interferon gamma) Hs00989291_m1
TGFB1 (Transforming growth factor beta-1 proprotein) Hs00998133_m1
CD14 (Monocyte differentiation antigen CD14) Hs02621496_s1
VEGFA (Vascular endothelial growth factor A) Hs00900055_m1
SLC2A1 (Solute carrier family 2, facilitated glucose transporter member 1) Hs00892681_m1
PKM (Pyruvate kinase PKM) Hs00761782_s1
SHPK (Sedoheptulokinase) Hs00950008_m1
Table 2. List of TaqMan® primers used for qPCR.
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Figure 5. Relative gene expression of human MDMs seeded in 6-well and 96-well plates, 24 h after M(LPS/
IC) stimulation (M1), M(IL-4/IL-10) stimulation (M2), or absence of stimulation (Mock). (A) Average RQ 
values of 6-well samples. (B) Average RQ values of 96-well samples. M1 and M2 values are relative to mock 
which is normalized to 1. Bars represent means of monoplicates of 3 independent experiments ± SEM. 
Technical replicates: individual wells of a 6-well plate, pool of thirty-two wells of a 96-well plate. Reference 
genes: SDHA, 18S, GAPDH. (C) Scatter plot showing the statistical comparison between seeding conditions for 
matched treatments in M(LPS/IC) and M(IL-4/IL-10) stimulated macrophages. Dashed lines correspond to the 
significance level ɑ = 0.05.
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material from two wells of cells seeded at the lowest number. Although we de facto analyzed the RNA extracted 
from 7,220 cells, these cells were cultured separately and thus represent cellular replicates. Our study highlights 
that working with a low cell number certainly imposes a limit on the quantity but not on the quality of the param-
eters (genes, in this study) analyzed.
The robustness of our analysis was tested by applying two different types of inflammatory stimuli to these very 
plastic cells that are well characterized for their swift response to any modification of the extracellular milieu. 
The stimuli we selected trigger different signaling pathways and activate different transcription factors, resulting 
in two very different molecular and functional profiles of macrophages. The gene expression profiles obtained 
after the pro- or the anti-inflammatory activation were evaluated using a restricted set of genes. This evaluation 
was confirmed in the analysis of a larger set of genes and showed the expected changes in the expression levels of 
specific genes in both setups (standard versus low number of cells). We thus detected the upregulation of TNF, 
SLC1A2 and IL1B after M(LPS/IC) stimulation or the upregulation of CD163, CD206 and SHPK24 after M(IL4/
IL10) stimulation. Moreover, we observed a remarkable similarity in the expression profiles of all genes displayed 
by both low and standard numbers of cells after the pro- or the anti-inflammatory activation. It thus appears 
that notwithstanding the use of a very sensitive type of cells (macrophages), the usual sources of technical (such 
as the batch effect) or biological variation (such as cell heterogeneity or plasticity) neither had an impact on the 
analysis of the low number of cells we determined nor did they compromise its reproducibility. This leads us to 
the assumption that this approach could be valid for other types of cells and could be used whenever the cellular 
material is limited.
Statistical analyses and network analyses with gene expression data of the larger set of genes provided further 
evidence for the reliability of the data obtained from the low number of cells. Indeed, similar lists of differen-
tially expressed genes and enriched pathways were obtained from both setups. Interestingly, the investigation of 
dysregulated genes from a protein network perspective suggested interaction between two metabolic enzymes, 
the gamma-glutamyl hydrolase (GGH) and the glutaminase (GLS), with the pro-inflammatory cytokine TNF, 
which are all upregulated after M(LPS/IC) stimulation. GGH is a critical enzyme in the regulation of folates. It 
is responsible for the intracellular cleavage of the poly g-glutamates25, releasing glutamate as one reaction prod-
uct. GLS is involved in glutamate/glutamine metabolism which is highly relevant to the inflammatory status of 
macrophages26,27. Whether and how these proteins interact and what functional meaning it would have for the 
immunometabolism of macrophages is worth investigating.
In closing, this study has focused on only one cell type, human macrophages, and one target of analysis, 
mRNA, as a proof of principle. We have used standard RT-qPCR and laboratory equipment to measure gene 
expression in these very plastic primary cells seeded at high and low cell numbers. The statistical and computa-
tional analysis of the gene expression profiles we have obtained in different conditions of cell seeding and treat-
ment prove our hypothesis that the analysis of a low number of cells is not only reliable, but also informative. 
Figure 6. Volcano plots showing the results of the differential gene expression analysis. Only genes that display 
the strongest alteration in expression in both the 6-well and 96-well setups are indicated by names. Genes whose 
change in expression was at least 1.5-fold larger than the standard condition and had an associated p-value of at 
most 0.05 are highlighted in blue. Genes for which only the first condition is met are shown in gray. (A–C) Data 
from the 6-well plate analysis. (D–F) Data from the 96-well plate analysis. Mock = untreated cells, M1 = M(LPS/
IC) macrophages, M2 = M(IL-4/IL-10) macrophages.
9Scientific RepoRtS |         (2019) 9:17908  | https://doi.org/10.1038/s41598-019-54500-8
www.nature.com/scientificreportswww.nature.com/scientificreports/
Having shown the soundness of our approach in this experimental framework, we hope this work will motivate 
further studies on different types of cells. Indeed, our study is of relevance for a wide range of biologists and bio-
medical scientists who could adapt the experimental workflow we provide to their own experimental needs and 
questions.
Materials and Methods
ethics statement. Buffy coats were purchased from the Transfusion Center of the University Medical 
Center of the Johannes Gutenberg University (Mainz, Germany) and were obtained from anonymized healthy 
blood donors. All buffy coats used in this study are residual biological materials made available by the Transfusion 
Center to scientists on a randomized basis. Blood samples are collected and processed in accordance with the 
relevant German guidelines and regulations. Personal data is neither collected nor shared for this material.
Monocyte isolation and differentiation into MDMs. Buffy coats were isolated from whole blood of 
healthy donors collected in CPD bags at the Transfusion Center (University Medical Center of the Johannes 
Figure 7. GO and pathway enrichment analysis of data generated from the 6-well and 96-well plate setups. 
Comparison of the M(LPS/IC) versus M(IL-4/IL-10) macrophages. (A) Upregulated terms in the 6-well setup. 
(B) Upregulated terms in the 96-well setup. (C) Downregulated terms in the 6-well setup. (D) Downregulated 
terms in the 96-well setup. BP, Biological Process; MF, Molecular Function; CC, Cellular Component.
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Gutenberg University). Briefly, after an initial centrifugation without a density gradient, the pelleted erythrocytes 
and the top plasma layer were transferred into new bags, leaving the interface (buffy coat) in the original bag. 
Each unit (approx. 460 ml) of whole blood yielded an approx. 60 ml buffy coat.
Peripheral blood mononuclear cells (PBMC) were isolated from buffy coats as follows. The total volume 
of each buffy coat was filled up with sterile PBS to a final volume of 120 ml. Afterwards, 10 ml Ficoll®-Paque 
PREMIUM 1.073 (GE Healthcare) were overlaid with 30 ml of the diluted blood and centrifuged (40 min, 400 
rcf, RT, without brake). The PBMC containing layer was isolated and centrifuged again (5 min, 450 rcf, RT). The 
cell pellet was resuspended in 10 ml erythrocyte lysis buffer (0.15 mM NH4Cl, 10 mM KHCO3, 0.1 mM EDTA, 
pH 7.2–7.4), incubated for 5 min on ice and centrifuged (5 min, 450 rcf, 4 °C). The pellet was resuspended in PBS, 
centrifuged (15 min, 200 rcf, RT), resuspended again in PBS and centrifuged (10 min, 450 rcf, RT). Finally, the 
pellet was resuspended in 1x NB complete medium [10 ng/ml basic fibroblast growth factor (PeproTech), 20 ng/
ml epidermal growth factor (PeproTech), B27™ supplement (Gibco) in Neurobasal™-A medium (Gibco)] and 
cells distributed on 10 cm Petri dishes (Sarstedt). After 2.5 h of incubation (37 °C, 5% CO2), supernatants were 
collected and replaced by cDMEM [DMEM (Sigma), 10% heat-inactivated FCS (Sigma), 2 mM L-Glutamine 
(Gibco), 50 µg/ml Gentamicin (Gibco)] containing 20 ng/ml macrophage-colony stimulating factor (M-CSF, 
Biolegend) for cell differentiation into MDMs. The collected supernatant was distributed on new 10 cm Petri 
dishes and incubated overnight (37 °C, 5% CO2) for a second round of cell attachment. The next day, superna-
tants were replaced by cDMEM containing 20 ng/ml M-CSF. All dishes were incubated for one week in cDMEM 
containing M-CSF and cultured for another week in cDMEM without M-CSF prior to experiments. At the end of 
these two weeks, cells displayed the typical morphology of macrophages and flow cytometry indicated that more 
than 94% of the cells expressed the CD11b protein (data not shown). Average yield is 8 × 106–1 × 107macrophages 
per preparation.
In vitro culture and stimulation. Each independent experiment was conducted with cells from one prepa-
ration. Monocyte-derived macrophages were seeded in tissue culture vessels of different size (tissue culture plates, 
Greiner), adapting cell number to vessel area in order to keep the cell density identical (Table 1). The smallest 
Figure 8. Direct protein-protein interaction partners (gray nodes) of proteins coded by differentially expressed 
genes (red nodes) according to the M1 vs M2 comparison from the low cell number setup.
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vessel we could assay was the well of a 96-well plate, hence the lowest number of cells to be tested was 3,610 cells. 
Cells were seeded in cDMEM and incubated for 24 h (37 °C, 5% CO2) to let cells attach and recover from scraping/
trypsinisation. Afterwards medium was removed and replaced by low serum-containing cDMEM (1% FCS) sup-
plemented or not with the inflammatory stimuli. Cells were thus left untreated or treated for another 24 h (37 °C, 
5% CO2) before analysis. Low serum-containing cDMEM was used in order to decrease potential side effects 
of FCS components during MDMs treatment (e.g. competition with stimuli). Treatment consisted of: 10 µg/
ml polyinosinic-polycytidylic acid (InvivoGen) combined with 10 ng/ml lipopolysaccharide (Sigma Aldrich) 
as pro-inflammatory stimulus; 10 ng/ml Interleukin-4 (BioLegend) combined with 10 ng/ml Interleukin-10 
(BioLegend) as anti-inflammatory stimulus. As recommended in28, macrophages are described according to the 
stimuli they were treated with: M(LPS/IC) and M(IL-4/IL-10). For space reasons, M(LPS/IC) and M(IL-4/IL-10) 
labels appear in graphs and legends as M1 and M2 respectively.
Determination of cell viability. After 24 h of treatment, PrestoBlue™ Cell viability reagent (ThermoFisher) 
was added directly to the wells in the culture medium according to manufacturers’ instructions. After 30 min of 
incubation at 37 °C (5% CO2) fluorescence was measured at a multiplate reader (TECAN Infinite® 200 PRO) and 
cell viability calculated as described in the manufacturers’ protocol.
Total RNA isolation, cDNA transcription and gene expression profiling. Isolation of total RNA 
was performed using RNeasy Mini Kit (Qiagen) according to manufacturers’ instructions. After PrestoBlue 
incubation, cells were washed with 1xPBS and lysed in Buffer RLT (containing 1% ß-mercaptoethanol). All fol-
lowing steps were conducted as described in the manufacturers’ protocol. RNA concentration and quality were 
determined using a Nanodrop 2200 (ThermoFisher). Only samples showing a 260/280 nm ratio between 1.8 
and 2.1 were selected for cDNA transcription which was performed with the Omniscript RT Kit (Qiagen) and 
random hexamers (Life Technologies). Quantitative PCR (qPCR) analysis was done using TaqMan® primers and 
a StepOnePlus System (Applied Biosystems). Briefly, for each well of the 96-well qPCR plate (Sarstedt), 10 µl of 
TaqMan™ Universal PCR Master Mix (ThermoFisher) were mixed with 5 ng cDNA and 1 µl of the appropriate 
primer (Table 2). All measurements were performed using three technical replicates. The PCR array was con-
ducted with a customized TaqMan® gene expression array plate (ThermoFisher) using the same conditions as 
mentioned above, without technical replicates. Relative quantification (RQ) of gene expression were determined 
using the 2−ΔΔCt method29. To ensure the robustness of the PCR analyses, we included two reference genes when 
measurements were performed with technical triplicates (data reported in Figs. 2 and 4) and three reference genes 
when measurements were performed without technical replicates (data reported in Fig. 5). The reference genes 
were determined among a set of four candidates (18S, SDHA, HPRT1, GAPDH) using the geNorm algorithm30. 
SDHA and HPRT1 were identified as the most stable genes in PCR conducted with technical triplicates. SDHA 
and 18 S, followed by GAPDH were identified as the most stable genes in PCR conducted without technical repli-
cates; HPRT1 had to be dismissed because of technical issues.
Statistical comparison between seeding conditions. To compare the RQ of gene expression between 
seeding in 6- and 96-well plates, we employed a two-tailed t-test under the null hypothesis that there were no dif-
ferences in expression between conditions. These tests were performed for matched treatments, i.e. mock 6-well 
vs mock 96-well, M1 6-well vs M1 96-well and M2 6-well vs M2 96-well. The resulting p-values were corrected for 
multiple comparisons using the Benjamini-Hochberg method.
Differential gene expression, functional enrichment and network analyses. We identified dif-
ferentially expressed genes between treatments (mock vs M1, mock vs M2, M1 vs M2) using log2-fold changes 
accompanied by p-values computed via t-tests. This was done separately for the 6- and 96-well seeding condi-
tions. Genes with absolute log2-fold changes ≥1.5 were considered to be up- or down-regulated. These genes were 
subjected to Gene Ontology (GO) and Reactome pathway enrichment analyses using the R package FunEnrich31. 
In addition, we constructed a protein-protein interaction network with the direct interactors of the genes showing 
at least a 1.5-fold up- or down-regulation in the M1 vs M2 stimulated macrophages. For this, we used experi-
mentally validated protein-protein interaction data from version 2.2 of the Human Integrated Protein-Protein 
Interaction rEference (HIPPIE)23. Only interactions with confidence scores above the upper quartile of the score 
distribution were considered.
Data availability
The datasets used and/or analyzed during the current study are available from the corresponding author on 
reasonable request.
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